Displaying 157 - 168 items out of 170 results
ILCN article
Closing Keynote Highlights Progress, Challenges in Management of SCLC
… Dr. Charles M. Rudin looked back on how small cell research has evolved and what needs remain. … Closing Keynote …
ILCN article
Studies Indicate Progress, Highlight Challenges of Combating Lung Cancer Stigma
… is helping to reduce the use of stigmatizing language, research on the effects of stigma in lung cancer is lacking. … …
ILCN article
LUNGevity: Lung Cancer’s Warrior in the Fight Against Misinformation
… health content often contains harmful information. Worse, research shows inaccurate data may attract more attention than …
Resource
… between patient and provider, prompt supplemental research and enable informed choices to be made regarding care …
ILCN article
Wellness Challenge to Return for WCLC 2023
… part in IASLC’s annual wellness challenge, Step It Up For Research. … Wellness Challenge to Return for WCLC 2023 … Erin …
ILCN article
US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR
… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …
ILCN article
Step it Up at WCLC 2025 in Barcelona
… audio. Participants can also support the IASLC’s future research initiatives and earn additional points by donating to …
ILCN article
More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care
… oncological surgery. Finally, oncology is the most active research field globally. constantly evolving treatment methods … summary, because of significant progress in oncological research for NSCLC, and because surgery is an early and …
ILCN article
2024 IASLC Academy to Once Again Compete in Amazing Case Race
… group of early career thoracic oncology clinicians and researchers has been a wonderful experience,” he said. …
ILCN article
Antibody Drug Conjugates: Diamonds in the Rough?
… the blood brain barrier, underscoring the need for more research into this phenomenon All in all, the future looks … TPS ≥50%: phase 3 KEYNOTE-D46/EVOKE-03 study. Cancer Research. 2023;83(8_Supplement):CT067-CT067. …










